NCT07201831

A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population

ACT on MASH: A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,330 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to collect information for scientific research and to better understand awareness and to understand overall risk awareness, diagnoses and treatment related to liver related diseases. The study aims to collect valid responses through online questionnaires from the participants. This study is a survey-based study without collection of laboratory data. It will take the participant 25 minutes to complete the survey. The study is not related to any specific treatment options or pharmaceutical product.

Conditions

• Metabolic Dysfunction-associated Steatohepatitis (MASH)

Interventions

Type	Name	Description
OTHER	No treatment given	No treatment given

Timeline

• Start date: 2025-10-02
• Primary completion: 2026-01-17
• Completion: 2026-01-17
• First posted: 2025-10-01
• Last updated: 2026-03-12

Locations

5 sites across 5 countries: United States, Canada, France, Germany, Japan